Sermorelin’s Safety and Efficacy in Treating Growth Hormone Deficiency in American Males
Reading Time: 2 minutes Introduction Growth hormone deficiency (GHD) in adults can lead to a variety of health issues, including reduced muscle mass, increased body fat, and decreased bone density. Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), has emerged as a potential treatment for GHD. This article delves into a recent Phase III clinical trial conducted to assess the safety and tolerability of Sermorelin in American males diagnosed with GHD, providing valuable insights into its clinical application. Study Design and Methodology The clinical trial was a randomized, double-blind, placebo-controlled study involving 200 American males aged 18 to 65 years with confirmed GHD....


